Gainers
-
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) rose
66.6 percent to $6.18 in pre-market trading after the company disclosed that Voclosporin met 48-week remission endpoints.
-
Vermillion, Inc. (NASDAQ: VRML) shares rose 20.9
percent to $2.84 in pre-market trading after the company reported a contracted in-network agreement with Blue Cross Blue Shield
of Michigan for OVA1.
-
Monster Beverage Corporation (NASDAQ: MNST) rose
12.5 percent to $47.26 in pre-market trading after the company reported upbeat revenue for its fourth quarter.
-
Charles Schwab Corp (NYSE: SCHW) rose 9.8 percent
to $47.20 in pre-market trading. Charles Schwab, Hong Kong, Ltd. disclosed that it will lower its standard online equity trade
commissions.
-
Ballard Power Systems Inc. (USA) (NASDAQ: BLDP)
shares rose 8.5 percent to $2.17 in pre-market trading as the company posted stronger-than-expected results for its fourth
quarter.
-
JD.Com Inc(ADR) (NASDAQ: JD) rose 8.2 percent to
$33.19 in pre-market trading. JD.com reported a Q4 loss of $0.18 per ADS on revenue of $11.558 billion. The company announced
plans to sell 28.6 percent stake in JD Finance for RMB 14.3 billion in cash.
-
EXACT Sciences Corporation (NASDAQ: EXAS) rose
6.1 percent to $23.50 in pre-market trading. Exact Sciences and Mayo Clinic study showed a promise of new blood-based lung
cancer test.
-
Glaukos Corp (NASDAQ: GKOS) shares rose 6 percent
to $48.50 in pre-market trading after reporting strong Q4 results.
-
Sarepta Therapeutics Inc (NASDAQ: SRPT) rose 5.3
percent to $32.00 in pre-market trading. Leerink Swann upgraded Sarepta Therapeutics from Market Perform to Outperform, while
Nomura initiated coverage on the stock with a Buy rating..
-
Broadcom Ltd (NASDAQ: AVGO) shares rose 5.3
percent to $226.50 in pre-market trading after the company reported stronger-than-expected results for its first quarter.
-
Burlington Stores Inc (NYSE: BURL) rose 3.2 percent
to $91.50 in pre-market trading as the company reported upbeat results for its fourth quarter.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
-
Adeptus Health Inc (NYSE: ADPT) fell 33.6 percent
to $4.35 in pre-market trading after dropping 2.96 percent on Wednesday.
-
Puma Biotechnology Inc (NASDAQ: PBYI) shares fell
30.4 percent to $26.50 in the pre-market trading session. Puma Biotechnology reported Q4 adjusted loss of $1.22 per share. Puma
Biotechnology also reported the publication of abstracts on neratinib for the AACR Annual Meeting 2017
-
Stage Stores Inc (NYSE: SSI) fell 28.9 percent to
$1.65 in pre-market trading after the company reported weaker-than-expected earnings for its fourth quarter and issued a
downbeat forecast for FY 2017.
-
AXT Inc (NASDAQ: AXTI) fell 12 percent to $6.60
in pre-market trading. AXT priced 4.6 million shares at $6.50 per share.
-
Methode Electronics Inc. (NYSE: MEI) fell around 9.8
percent to $39.10 in pre-market trading. Methode posted upbeat Q3 earnings, but lowered its sales forecast.
-
Ares Management LP (NYSE: ARES) fell 8.9 percent to
$20.05 in pre-market trading. Ares Management reported the launch of 7.5 million unit secondary offering.
-
Juno Therapeutics Inc (NASDAQ: JUNO) dropped 6.8
percent to $23.60 in pre-market trading. Juno Therapeutics reported a Q4 loss of $0.51 per share on revenue of $21.153 million.
Juno also announced plans to end development of its cancer drug.
-
Ashford Hospitality Prime Inc (NYSE: AHP) shares
fell 6.5 percent to $12.06 in pre-market trading. Ashford Prime reported a 1.15 million share offering of common stock and
announced plans to acquire Hotel Yountville for $96.5 million.
-
Kratos Defense & Security Solutions, Inc (NASDAQ: KTOS) fell 6.1 percent to $7.54 in pre-market trading after reporting a
proposed public offering of common stock.
-
Centrus Energy Corp (NYSE: LEU) shares fell 5.7
percent to $5.60 in pre-market trading after declining 2.46 percent on Wednesday.
-
HTG Molecular Diagnostics Inc (NASDAQ: HTGM)
shares fell 5.4 percent to $3.00 in pre-market trading after rising 16.12 percent on Wednesday.
-
Opko Health Inc. (NASDAQ: OPK) fell 4.7 percent to
$7.98 in pre-market trading. OPKO Health reported a Q4 loss of $0.04 per share on revenue of $275.5 million.
-
Kite Pharma Inc (NASDAQ: KITE) fell 4.8 percent
to $75.80 in pre-market trading. Kite reported commencement of 4.75 million share offering. Citigroup downgraded Kite Pharma
from Buy to Neutral.
-
Anheuser Busch Inbev NV (ADR) (NYSE: BUD) fell 3.8
percent to $105.75 in pre-market trading on weak quarterly earnings. Bank of America downgraded Anheuser-Busch Inbev from Buy
to Neutral.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.